Answers are grounded in this paper and cite their sources.
A significant proportion of patients presenting with large locally advanced breast tumours, treated with neoadjuvant chemotherapy (NAC), show a poor or partial response to the treatment. The aim of this study is to identify novel phospho-proteins that may predict responsiveness to NAC treatment as there are no such biological markers available in the clinic to date.
No takes yet. Share an insight, caveat, or question.
Greenwood et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: